AVH · ASX

AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs (ASX:AVH)

AU$3.75

 0.05 (1.351%)
ASX:Live
20/12/2024 04:10:10 PM
Recent Price upgrade HALO Ords GROWTH AUS Fakey Shakey - Short EMA 125 Breakup +2
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

AVH Overview

AVH Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Neutral

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Neutral

About AVH

Website

AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs

Telephone

1.833.462.8482

Address

Suite 220 28159 Avenue Stanford Valencia, CA 91355

Description

AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.

AVH Price Chart

Key Stats

Market Cap

AU$520.57M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 2.34 - 5.62

Trade Value (12mth)

AU$226,895.00

1 week

-6.09%

1 month

-5.13%

YTD

-10.41%

1 year

-5.61%

All time high

104.14

Key Fundamentals

EPS 3 yr Growth

-31.90%

EBITDA Margin

-242.00%

Operating Cashflow

-$57m

Free Cash Flow Return

-44.40%

ROIC

-41.30%

Interest Coverage

-106.20

Quick Ratio

7.50

Other Data

Shares on Issue (Fully Dilluted)

130m

HALO Sector

Healthcare

Next Company Report Date

20-Feb-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.29

AVH Announcements

Latest Announcements

Date Announcements

20 December 24

AVITA Medical Announces FDA 510(k) Clearance for Cohealyx

×

AVITA Medical Announces FDA 510(k) Clearance for Cohealyx

19 December 24

AVITA Medical to Present at JP Morgan Healthcare Conference

×

AVITA Medical to Present at JP Morgan Healthcare Conference

18 December 24

Notification regarding unquoted securities - AVH

×

Notification regarding unquoted securities - AVH

18 December 24

Notice under section 708A(5)(e) of the Corporations Act

×

Notice under section 708A(5)(e) of the Corporations Act

10 December 24

Notification regarding unquoted securities - AVH

×

Notification regarding unquoted securities - AVH

10 December 24

Notice under section 708A(5)(e) of the Corporations Act

×

Notice under section 708A(5)(e) of the Corporations Act

06 December 24

Statement of CDIs on issue - AVH

×

Statement of CDIs on issue - AVH

06 December 24

Notification regarding unquoted securities - AVH

×

Notification regarding unquoted securities - AVH

06 December 24

Notice under section 708A(5)(e) of the Corporations Act

×

Notice under section 708A(5)(e) of the Corporations Act

05 December 24

Notification of cessation of securities - AVH

×

Notification of cessation of securities - AVH

04 December 24

AVITA Medical December 2024 Investor Presentation

×

AVITA Medical December 2024 Investor Presentation

28 November 24

Notification regarding unquoted securities - AVH

×

Notification regarding unquoted securities - AVH

28 November 24

Notice under section 708A(5)(e) of the Corporations Act

×

Notice under section 708A(5)(e) of the Corporations Act

26 November 24

AVITA Medical to Present at the Piper Healthcare Conference

×

AVITA Medical to Present at the Piper Healthcare Conference

26 November 24

Notification regarding unquoted securities - AVH

×

Notification regarding unquoted securities - AVH

26 November 24

Notice under section 708A(5)(e) of the Corporations Act

×

Notice under section 708A(5)(e) of the Corporations Act

21 November 24

Notification regarding unquoted securities - AVH

×

Notification regarding unquoted securities - AVH

21 November 24

Notice under section 708A(5)(e) of the Corporations Act

×

Notice under section 708A(5)(e) of the Corporations Act

14 November 24

Notification regarding unquoted securities - AVH

×

Notification regarding unquoted securities - AVH

14 November 24

Notice under section 708A(5)(e) of the Corporations Act

×

Notice under section 708A(5)(e) of the Corporations Act

13 November 24

AVITA Medical to Expand into Australia and New Zealand

×

AVITA Medical to Expand into Australia and New Zealand

13 November 24

AVITA Medical Q3 2024 Investor Presentation

×

AVITA Medical Q3 2024 Investor Presentation

08 November 24

AVITA Medical Reports Third Quarter Financial Results

×

AVITA Medical Reports Third Quarter Financial Results

08 November 24

Financial Results for Quarter Ending 30 September 2024

×

Financial Results for Quarter Ending 30 September 2024

AVH Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.31 -0.31 -0.42 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.31 -0.31 -0.42 Lock Lock Lock
     Growth % Lock Lock Lock Lock 49.1 2.1 -36.8 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.20 -0.20 -0.37 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.32 -0.23 -0.47 Lock Lock Lock
     Growth % Lock Lock Lock Lock 40.3 -2.5 -80.1 Lock Lock Lock
     Yield % Lock Lock Lock Lock -6.1 -11.5 -10.9 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 1.24 0.99 0.56 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 1.23 0.99 0.55 Lock Lock Lock
     Growth % Lock Lock Lock Lock 26.4 -20.0 -43.8 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 113 125 127 Lock Lock Lock
Basic m Lock Lock Lock Lock 113 125 127 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 39 50 76 Lock Lock Lock
     Growth % Lock Lock Lock Lock 84.2 26.7 52.1 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 70 85 249 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 31 41 64 Lock Lock Lock
     Growth % Lock Lock Lock Lock 85.3 31.2 55.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 79.6 82.4 84.5 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 20 18 16 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -36 -42 -183 Lock Lock Lock
     Growth % Lock Lock Lock Lock 46.5 -15.7 -333.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -92.9 -84.9 -242.0 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 2 2 3 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -38 -44 -185 Lock Lock Lock
     Growth % Lock Lock Lock Lock 44.9 -15.9 -317.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -97.8 -89.5 -245.4 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -36 -38 -53 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -36 -38 -53 Lock Lock Lock
     Growth % Lock Lock Lock Lock 43.2 -7.9 -38.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -90.9 -77.5 -70.6 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -35 -28 -57 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 2 1 2 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -2 -28 2 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 86 1 61 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -36 -28 -59 Lock Lock Lock
     Growth % Lock Lock Lock Lock -3.2 21.5 -110.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.9 -0.6 -0.8 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 148 117 131 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 167 145 164 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 0 61 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -146 -116 -68 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 13 17 85 Lock Lock Lock
Equity $m Lock Lock Lock Lock 154 125 72 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 155 125 133 Lock Lock Lock
     Growth % Lock Lock Lock Lock 43.8 -19.2 5.8 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -21.3 -26.5 -32.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -23.1 -30.8 -74.1 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -28.9 -31.5 -142.4 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -27.1 -27.4 -41.3 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -26.4 -19.6 -44.4 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -1,234.5 -1,825.8 -106.2 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 4.0 2.7 0.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -94.6 -92.5 -95.1 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 16.4 8.2 7.9 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 16.2 8.0 7.5 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 91.4 90.7 85.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -352.7 -174.6 -296.0 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 5.5 5.7 8.1 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 4.2 3.3 2.1 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.3 0.4 0.6 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 10.6 8.9 7.4 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.2 0.3 0.5 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.2 0.3 0.5 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -90.8 -77.4 -70.4 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -21.3 -26.5 -32.5 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -21.3 -26.5 -32.6 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.2 2.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -23.1 -30.8 -74.1 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -23.1 -30.8 -74.1 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 87.6 111.6 176.5 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 65.9 64.1 44.9 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 153.5 175.7 221.4 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 223.4 162.2 108.5 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -70.0 13.4 112.8 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.29%

Value ($M)

1

Prior Change

N/A

7 Day Change

0.10%

1 Month Change

0.10%

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

AVH Shortsell

Frequently Asked Questions

The current share price of AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs (AVH:ASX) is AU$3.75.
The 52-week high share price for AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs (AVH:ASX) is AU$5.62.
The 52-week low share price for AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs (AVH:ASX)? is AU$2.34.
AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs (AVH:ASX) does not pay a dividend.
AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs (AVH:ASX) does not pay a dividend.
AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs (AVH:ASX) has a franking level of 0.0%.
AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs (AVH:ASX) is classified in the Healthcare.
The current P/E ratio for AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs (AVH:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.